Key Developments: Greenway Medical Technologies Inc (GWAY.N)
11.78USD
23 May 2013
$0.08 (+0.68%)
$11.70
$11.68
$11.82
$11.52
31,919
26,412
$19.60
$11.52
Latest Key Developments (Source: Significant Developments)
Greenway Medical Technologies Inc Lowers FY 2013 Guidance
Greenway Medical Technologies announced that it has revised its guidance for fiscal 2013 and expects revenue of $132.0 million to $134.0 million, operating income of $(7.0) to $(6.0) million, GAAP Net income of $(3.7) to $(3.2) million, GAAP EPS of $(0.13) to $(0.11) and adjusted EBITDA of $5.8 to $6.8 million and adjusted EPS of $0.21 to $0.28. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $145 million, EBIT of $7.3 million, net income of $6.4 million, EBITDA of $17.2 million and EPS of $0.22 for fiscal 2013. Full Article
Greenway Medical Technologies Inc Lowers FY 2013 Guidance
Greenway Medical Technologies announced that it has revised its guidance for fiscal 2013 and now expects revenue of $145.0 million to $150.0 million, operating income of $5.5 to $8.3 million, Net income of $3.1 to $5.2 million, GAAP EPS of $0.10 to $0.17 and adjusted EBITDA of $18.0 to $21.0 million and adjusted EPS of $0.21 to $0.28. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $151 million, EBIT of $11.2 million, net income of $8.23 million, EBITDA of $20.31 million and EPS of $0.27 for fiscal 2013. Full Article
Greenway Medical Technologies Inc Issues FY 2013 Guidance; EBIT, Net Income And EPS Guidance Below Analysts' Estimates
Greenway Medical Technologies announced that for fiscal 2013, it expects revenue of $149-$156 million, operating income of $8-$10 million, Net income of $4.8-$6.1 million, GAAP EPS of $0.15-$0.20, adjusted EBITDA of $19.3-$23.4 million and adjusted EPS of $0.27-$0.31. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $153 million, EBIT of $15 million, net income of $9.71, EBITDA of $21.41 and EPS of $0.33 for fiscal 2013. Full Article
Greenway Medical Technologies Inc Raises FY 2012 Revenue Guidance-Conference Call
Greenway Medical Technologies Inc announced that it expects overall revenue growth to be in excess of original target of 25% to 30% for fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $122 million for fiscal 2012. Full Article
Greenway Medical Technologies Inc Comments On FY 2012 Revenue Guidance-Conference Call
Greenway Medical Technologies Inc announced that overall revenue growth for fiscal 2012 to be in the 25% to 30% range. Full Article
Greenway Medical Technologies, Inc. Announces Pricing Of Initial Public Offering-Investment Weekly News
Investment Weekly News reported that Greenway Medical Technologies, Inc. pricing its initial public offering (IPO) of 6,666,667 shares of common stock at $10.00 per share. Greenway is offering 5,388,833 shares of common stock and selling stockholders are offering 1,277,834 shares of common stock. In addition, the underwriters were granted a 30 day option to purchase up to 1,000,000 additional shares of common stock from Greenway at the initial public offering price. Greenway will not receive any proceeds from the sale of shares by the selling stockholders. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol GWAY on February 2, 2012. Full Article
Healthcare Systems Nationwide Selects Greenway Medical Technologies, Inc.'s PrimeSUITE EHR
Hospital and medical group systems in California, Rhode Island and Georgia announced recent samplings of institutions selecting Greenway Medical Technologies, Inc.'s integrated electronic health record (EHR), practice management and interoperability solution PrimeSUITE 2011 to advance patient care and delivery and clinical care coordination structures. In addition to selecting the core functionality of PrimeSUITE, the systems are making a range of integrated solutions available to medical staff and affiliated clinics, including Greenway's data aggregation and care coordination solution PrimeDATACLOUD, online patient portal PrimePATIENT, clinician understanding solution PrimeSPEECH, remote clinic PrimeMOBILE and advanced PACS solution PrimeIMAGE. Full Article
Greenway Medical Technologies, Inc. Announces Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Initial Public Offering
Greenway Medical Technologies, Inc. announced that the underwriters of Greenway's recent initial public offering of its common stock exercised in full their option to purchase an additional 1,000,000 shares of common stock at $10.00 per share, less underwriting discounts and commissions. The option was granted in connection with Greenway's initial public offering of 6,666,667 shares. As a result, the total initial public offering size is 7,666,667 shares, which consists of 6,388,833 shares sold by Greenway and 1,277,834 shares sold by the selling stockholders. Including proceeds from the exercise of the option, net proceeds to Greenway from the initial public offering are approximately $57.2 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by Greenway. Greenway did not receive any proceeds from the sale of shares by the selling stockholders. The closing of the sale of all 7,666,667 shares of Greenway's common stock to the underwriters occurred. J.P. Morgan and Morgan Stanley acted as active book-runners and William Blair acted as passive book-runner. Full Article
Greenway Medical Technologies, Inc. Announces Pricing Of Initial Public Offering
Greenway Medical Technologies, Inc. announced the pricing of its initial public offering of 6,666,667 shares of common stock at $10.00 per share. Greenway is offering 5,388,833 shares of common stock and selling stockholders are offering 1,277,834 shares of common stock. In addition, the underwriters were granted a 30-day option to purchase up to 1,000,000 additional shares of common stock from Greenway at the initial public offering price. Greenway will not receive any proceeds from the sale of shares by the selling stockholders. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol GWAY on February 2, 2012. J.P. Morgan and Morgan Stanley are acting as active book-runners and William Blair is acting as passive book-runner. Full Article
Greenway Medical Technologies, Inc. To Acquire Assets Of CySolutions, Inc.
Greenway Medical Technologies, Inc. announced that it is acquiring certain technology assets of CySolutions, Inc., provider of integrated information technology solutions for Federally Qualified Health Centers (FQHCs) and Community Health Centers (CHCs). Financial details of the transaction were not disclosed. The transaction is expected to close by October 31, 2011. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
